Similarly, Nusinersen (Spinraza) is a therapeutic oligonucleotide used in spinal muscular atrophy (SMA) to induce alternative splicing of the SMN2 (survival motor neuron 2) gene, a paralog of SMN1 that is deficient in SMA. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.